111 related articles for article (PubMed ID: 7647107)
1. Production and purification of active FGF2 via recombinant fusion protein.
Lemaître G; Laaroubi K; Soulet L; Barritault D; Miskulin M
Biochimie; 1995; 77(3):162-6. PubMed ID: 7647107
[TBL] [Abstract][Full Text] [Related]
2. Functional efficacy of human recombinant FGF-2s tagged with (His)
Lee JH; Lee JE; Kang KJ; Jang YJ
Protein Expr Purif; 2017 Jul; 135():37-44. PubMed ID: 28487257
[TBL] [Abstract][Full Text] [Related]
3. Expression and purification of recombinant proteins by fusion to maltose-binding protein.
Riggs P
Mol Biotechnol; 2000 May; 15(1):51-63. PubMed ID: 10911622
[TBL] [Abstract][Full Text] [Related]
4. High level expression and purification of the Epstein-Barr virus encoded cytokine viral interleukin 10: efficient removal of endotoxin.
Salek-Ardakani S; Stuart AD; Arrand JE; Lyons S; Arrand JR; Mackett M
Cytokine; 2002 Jan; 17(1):1-13. PubMed ID: 11886166
[TBL] [Abstract][Full Text] [Related]
5. Protein purification with C-terminal fusion of maltose binding protein.
Hennig L; Schäfer E
Protein Expr Purif; 1998 Dec; 14(3):367-70. PubMed ID: 9882570
[TBL] [Abstract][Full Text] [Related]
6. Engineering, expression, and renaturation of a collagen-targeted human bFGF fusion protein.
Andrades JA; Wu LT; Hall FL; Nimni ME; Becerra J
Growth Factors; 2001; 18(4):261-75. PubMed ID: 11519825
[TBL] [Abstract][Full Text] [Related]
7. Affinity Purification of a Recombinant Protein Expressed as a Fusion with the Maltose-Binding Protein (MBP) Tag.
Duong-Ly KC; Gabelli SB
Methods Enzymol; 2015; 559():17-26. PubMed ID: 26096500
[TBL] [Abstract][Full Text] [Related]
8. Engineering of an FGF-proteoglycan fusion protein with heparin-independent, mitogenic activity.
Yoneda A; Asada M; Oda Y; Suzuki M; Imamura T
Nat Biotechnol; 2000 Jun; 18(6):641-4. PubMed ID: 10835602
[TBL] [Abstract][Full Text] [Related]
9. Expression and purification of biologically active human FGF2 containing the b'a' domains of human PDI in Escherichia coli.
Song JA; Koo BK; Chong SH; Kwak J; Ryu HB; Nguyen MT; Vu TT; Jeong B; Kim SW; Choe H
Appl Biochem Biotechnol; 2013 May; 170(1):67-80. PubMed ID: 23471584
[TBL] [Abstract][Full Text] [Related]
10. Characterization of purified recombinant Bet v 1 with authentic N-terminus, cloned in fusion with maltose-binding protein.
Spangfort MD; Ipsen H; Sparholt SH; Aasmul-Olsen S; Larsen MR; Mørtz E; Roepstorff P; Larsen JN
Protein Expr Purif; 1996 Nov; 8(3):365-73. PubMed ID: 8936599
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of decorin core protein expressed in Escherichia coli as a maltose-binding protein fusion.
Hering TM; Kollar J; Huynh TD; Varelas JB
Anal Biochem; 1996 Aug; 240(1):98-108. PubMed ID: 8811884
[TBL] [Abstract][Full Text] [Related]
12. High-level expression of soluble protein in Escherichia coli using a His6-tag and maltose-binding-protein double-affinity fusion system.
Pryor KD; Leiting B
Protein Expr Purif; 1997 Aug; 10(3):309-19. PubMed ID: 9268677
[TBL] [Abstract][Full Text] [Related]
13. Refolding and characterization of human recombinant heparin-binding neurite-promoting factor.
Seddon AP; Hulmes JD; Decker MM; Kovesdi I; Fairhurst JL; Backer J; Dougher-Vermazen M; Böhlen P
Protein Expr Purif; 1994 Feb; 5(1):14-21. PubMed ID: 8167469
[TBL] [Abstract][Full Text] [Related]
14. An FGF1:FGF2 chimeric growth factor exhibits universal FGF receptor specificity, enhanced stability and augmented activity useful for epithelial proliferation and radioprotection.
Motomura K; Hagiwara A; Komi-Kuramochi A; Hanyu Y; Honda E; Suzuki M; Kimura M; Oki J; Asada M; Sakaguchi N; Nakayama F; Akashi M; Imamura T
Biochim Biophys Acta; 2008 Dec; 1780(12):1432-40. PubMed ID: 18760333
[TBL] [Abstract][Full Text] [Related]
15. Expression and purification of maltose-binding protein fusions.
Riggs P
Curr Protoc Mol Biol; 2001 May; Chapter 16():Unit16.6. PubMed ID: 18265133
[TBL] [Abstract][Full Text] [Related]
16. Expression of recombinant human phenylalanine hydroxylase as fusion protein in Escherichia coli circumvents proteolytic degradation by host cell proteases. Isolation and characterization of the wild-type enzyme.
Martinez A; Knappskog PM; Olafsdottir S; Døskeland AP; Eiken HG; Svebak RM; Bozzini M; Apold J; Flatmark T
Biochem J; 1995 Mar; 306 ( Pt 2)(Pt 2):589-97. PubMed ID: 7887915
[TBL] [Abstract][Full Text] [Related]
17. Improved expression and purification of sigma 1 receptor fused to maltose binding protein by alteration of linker sequence.
Gromek KA; Meddaugh HR; Wrobel RL; Suchy FP; Bingman CA; Primm JG; Fox BG
Protein Expr Purif; 2013 Jun; 89(2):203-9. PubMed ID: 23562661
[TBL] [Abstract][Full Text] [Related]
18. An Escherichia coli vector to express and purify foreign proteins by fusion to and separation from maltose-binding protein.
Maina CV; Riggs PD; Grandea AG; Slatko BE; Moran LS; Tagliamonte JA; McReynolds LA; Guan CD
Gene; 1988 Dec; 74(2):365-73. PubMed ID: 3073105
[TBL] [Abstract][Full Text] [Related]
19. Dimerization capacities of FGF2 purified with or without heparin-affinity chromatography.
Platonova N; Miquel G; Chiu LY; Taouji S; Moroni E; Colombo G; Chevet E; Sue SC; Bikfalvi A
PLoS One; 2014; 9(10):e110055. PubMed ID: 25299071
[TBL] [Abstract][Full Text] [Related]
20. Stable Fibroblast Growth Factor 2 Dimers with High Pro-Survival and Mitogenic Potential.
Nawrocka D; Krzyscik MA; Opaliński Ł; Zakrzewska M; Otlewski J
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32526859
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
